Please ensure Javascript is enabled for purposes of website accessibility

Why Marijuana Stocks Wilted Today

By Rich Smith - Updated Jan 25, 2021 at 4:28PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analysts point out: Oversupply and falling prices aren't good for profits.

What happened

Marijuana stocks' three-month run higher appeared to hit a brick wall Monday, with shares of Aurora Cannabis (ACB 7.75%) closing 4.6% lower, HEXO (HEXO 5.87%) dropping 8.7%, and Aphria (APHA) stock falling 7%. Fellow marijuana grower Tilray (TLRY), with which Aphria is merging, also closed the day down, 4.6%.

Only one of these four cannabis companies was mentioned in the news today, and that was a positive report. 

Wilted marijuana plants

Image source: Getty Images.

So what

Early Monday morning, analysts at Cantor Fitzgerald raised their price target on Aurora Cannabis by 33%, reports Although Cantor kept its neutral rating, its new price target of $12.55 implies there's actually quite a bit of upside left in the stock at 23.5%.

But as MarketWatch reported in the afternoon (after the price target hike), there have been some rumblings on Wall Street that all may not be well with the marijuana industry. Foothill Capital Management's Korey Bauer was quoted worrying about oversupply in Canada. Alliance Global Partners analyst Aaron Grey also warned that pricing pressure persists.  

Now what

Not all the news is bad. The Province of Ontario is apparently getting ready to increase the number of stores authorized to sell cannabis, Grey said. And even if legalization doesn't happen at the federal level in the U.S. this year, Grey suggests that marijuana-favorable state laws remain a positive catalyst.

The question is whether the increase in sales in Canada and in the U.S. will be enough to soak up Canada's oversupply of cannabis. Otherwise prices will fall, as will profits.

In fact, data from S&P Global Market Intelligence shows that neither Aurora Cannabis nor Aphria has booked a GAAP profit since 2018, and HEXO hasn't earned a profit ever.

Now, all three companies need to dig themselves out of a hole just to break even -- in an economic environment characterized by oversupply and falling prices.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$1.53 (7.75%) $0.11
HEXO Stock Quote
$0.24 (5.87%) $0.01
Tilray Stock Quote
Aphria Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.